Press release
Preference for Minimally Invasive Procedures to Encourage Growth of Global Deep Brain Stimulation Devices Market for Parkinson’s Disease, TMR Says
Since its inception about three decades ago, the fundamentals of software and hardware design for deep brain stimulation (DBS) have largely remained stagnant. However, improved understanding of disease progression pertaining to movement disorders combined with patient and clinician demands has led to the development of more advanced DBS technology. This will open growth avenues for deep brain stimulation and its allied realms, according to a research report by Transparency Market Research.Avail Free Sample Research Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1435
While new electrode design for deep brain stimulation devices has enabled multi-target stimulation sans side-effects, new user-friendly software enables computational modelling and individualized directed programming.
Q. What is the usability of DBS devices for Parkinson’s disease?
A. The use of deep brain stimulation for Parkinson’s disease involves treating several disabling neurological symptoms such as tremor, slowed movement, rigidity, stiffness, and walking problems. While drug therapy is most commonly used for the treatment of Parkinson’s disease in initial stages, surgical intervention using DBS devices are used to control the symptoms of the disease in advanced stages.
DBS devices are effective, clinically proven and have received legal approvals for the advanced treatment of mild to severe form of Parkinson’s disease. The endorsements for the usability of these devices will benefit the growth of the deep brain stimulation devices market.
Q. How have technological advances benefitted the growth of the DBS devices market?
A. Tremendously. In a recent industry development, GlaxoSmithKline and Verily have joined hands to establish Galvani Bioelectronics – a joint venture for the development miniature implantable devices to modify nerve signals and also to collect information about the body’s neural networks. These miniature devices are designed to communicate with a hand-held receiver and leverage analytics and to treat patients more precisely.
This technology has been announced as bioelectronics medicine that works on the target area, unlike drugs that affect the entire body.
Q. What are the major factors propelling the growth of deep brain stimulation devices market?
A. The global deep brain stimulation devices market is driven by several factors. A rising geriatric population globally, an increasing incidence of Parkinson’s disease, and rising awareness about neurological movement disorders is fuelling the growth of this market. Moreover, favorable reimbursement policies are also contributing to the growing acceptance of these devices across the world.
Browse Full Research Report: http://www.transparencymarketresearch.com/deep-brain-stimulator-market.html
Q. What are the factors holding back the growth of the deep brain stimulation devices market?
A. The risks associated with deep brain stimulation surgeries are the foremost factor holding back the market’s growth. Furthermore, the implementation of certain governmental policies such as the Affordable Care Act in the U.S. will hinder the growth of this market to some extent.
The high-cost factor of deep brain stimulation surgical procedure is also restraining the market’s growth. However, the growing burden of Parkinson’s disease on healthcare systems of developed countries has necessitated original equipment manufacturers (OEMs) to develop cost-effective devices for the treatment of Parkinson’s disease.
About Us
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
TMR’s data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.
Contact Us
Transparency Market Research
State Tower,
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Preference for Minimally Invasive Procedures to Encourage Growth of Global Deep Brain Stimulation Devices Market for Parkinson’s Disease, TMR Says here
News-ID: 356037 • Views: …
More Releases from TMR - MD
Technological Advancements in Endoscopic Procedures have Resulted in Several Imp …
Medical videoscopes help to enhance the visualization system during various surgeries enabling health care experts to closely observe body cavities and organs. Videoscopes contain specific software that creates dynamic 3D images from the output of computed tomography (CT), magnetic resonance imaging (MRI) and other scanners. The images are thereby used by health care professionals to improve the diagnosis of serious medical conditions. Medical videoscopes are usually 10 mm or lesser…

Dental Pain Market is teeming with opportunities for established players as well …
A new research study by Transparency Market Research (TMR) provides a comprehensive assessment of the global dental pain market. The report, titled “Dental Pain Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020,” is available for sale on TMR’s website.
According to the research report, the global dental pain market is teeming with opportunities for established players as well as new entrants. The market also provides…
Febrile Neutropenia Market: Majorly driven by the efforts of key players to deve …
Febrile neutropenia is defined as the development of fever with sign of infection. Febrile neutropenia is one of the most severe complications during cancer chemotherapy and is mainly caused by infectious agents like gram positive and gram negative bacteria. This diseased condition significantly reduces white blood cell count of the patients. Blood test is helpful to determine the number of white blood cells and to diagnose febrile neutropenia disease. Additionally,…
Glenoid Implant System Market: Strategies of key players and products offered
Glenoid implants are mainly used for hemiarthroplasty. Hemiarthroplasty involves replacing just the joint surface of the humeral head with a cap-like prosthesis without a stem. In shoulder replacement surgery, the damaged parts of the shoulder are removed and replaced with artificial components, called a prosthesis. The treatment options are either replacement of just the head of the humerus bone (ball), or replacement of both the ball and the socket called…
More Releases for Parkinson’s
Parkinson’s Disease Treatment Market 2021 | Detailed Report
Parkinson’s Disease Treatment Market Forecasts report provided to identify significant trends, drivers, influence factors in global and regions, agreements, new product launches and acquisitions, Analysis, market drivers, opportunities and challenges, risks in the market, cost and forecasts to 2027.
Get Free Sample PDF (including full TOC, Tables and Figures) of Parkinsons Disease Treatment Market @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=5024082
The report provides a comprehensive analysis of company profiles listed below:
- Teva
- Roche
- Prothena
- Acorda…
Parkinson’s Disease Treatment Market Size, Share, Development by 2024
Global Info Research offers a latest published report on Parkinson’s Disease Treatment Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key global Parkinson’s Disease Treatment players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Parkinson’s Disease Treatment with respect…
US Parkinson’s Disease Drug Pipeline Analysis
Parkinson’s disease incidence has been on a rise in the United States in recent years and it most likely to continue rising in the near future. It has been estimated that at least 500,000 people in the United States currently have been diagnosed with this disease. The society pays a significant amount towards treating this disease in the country. It is estimated that the total cost to the nation exceeds…
Europe Parkinson’s Disease Drug Pipeline Analysis
Parkinson’s disease incidence has been on a rise in Europe in recent years and it most likely to continue rising in the near future. It has been estimated that currently, more than 1 million in Europe are affected by Parkinson’s disease. This figure is most likely to double by 2030. Among the most common neurodegenerative disease (after Alzheimer’s disease), Parkinson’s is the second most common and it is expected that…
Parkinson’s Disease - Heat Map and Analysis
ReportsWorldwide has announced the addition of a new report title Parkinson’s Disease - Heat Map and Analysis to its growing collection of premium market research reports.
Parkinson’s disease (PD) is a chronic and progressive neurodegenerative disorder characterized by the progressive loss of muscular control, leading to resting tremor, rigidity, akinesia and postural reflex impairment. PD is an age-related disorder; symptoms typically begin to first appear in patients in their mid-sixties,…
New Education Options for Parkinson’s Caregivers
(4/30/2012- Gilbert, Ariz.) When a loved one is diagnosed with Parkinson’s Disease (PD), it becomes clear that Parkinson’s is a life- changing experience for the entire family — particularly for the primary care provider, who is most often a spouse, child or parent.
Family caregivers may not think of themselves as a care providers or recognize their new caregiving tasks. As family members begin helping with doctor visits, taking over financial…